Compositions comprising a serotonergic tryptamine compound
AssigneeCaamtech, Inc.
InventorAndrew R. Chadeayne
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions comprising a serotonergic tryptamine compound, combinations thereof, and methods of using them for treating and preventing a variety of human conditions. In one embodiment, disclosed herein are new compositions and methods which comprise a therapeutically effective amount of a first purified psilocybin derivative and a therapeutically effective amount of a second compound. The second compound is selected from the group consisting of a second purified psilocybin derivative, a purified terpene, a serotonergic drug, an adrenergic drug, a dopaminergic drug, a purified erinacine, and a purified hericenone.
Claims3
A dosage composition comprising:
- a first purified psilocybin derivative selected from the group consisting of [3-(2-Dimethylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate, 4-hydroxy-N,N-dimethyltryptamine, 3-(2-methylaminoethyl)-1H-indol-4-yl] dihydrogen phosphate, 4-hydroxy-N-methyltryptamine, [3-(aminoethyl)-1H-indol-4-yl] dihydrogen phosphate, 4-hydroxytryptamine, [3-(2-trimethylaminoethyl)-1H indol-4-yl] dihydrogen phosphate, and 4-hydroxy-N,N,N-trimethyltryptamine;
- and
- a dopaminergic drug.
Dependencies are inferred from the claim text.